VYGR סך נכסי הפעילות העסקית Voyager Therapeutics Inc
Voyager Therapeutics (VYGR) focuses on developing genetic material transport systems for neurons to treat severe brain pathologies. This daily price chart for the company, which holds total assets of 259.90, confirms the financial foundation necessary to advance intellectual property protections and execute joint projects for dementia treatment. The company is currently implementing automated complexes where robotics accelerate the selection of the most effective viral vectors.
פילוחים אנליטיים ודוחות נתונים של חברת Voyager Pharma (VYGR)
Total assets represent the aggregate value of all corporate resources, defining the scale of the company's financial base. This chart of gross assets reflects the current valuation of Voyager Therapeutics (VYGR) property at 259.90. This metric is calculated inversely via the ROA indicator, allowing for the real-time tracking of balance sheet changes. For Voyager Therapeutics (VYGR), the growth of this indicator confirms the effective capitalization of the Tracer platform's intellectual property and revenues from pharmaceutical licenses.